Document Detail


The community use of rescue medication for prolonged epileptic seizures in children.
MedLine Citation:
PMID:  19135392     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The objectives for this study were to determine the prevalence of use, safety and efficacy of different preparations of rescue medication used for prolonged seizures in children in the community and to use the information gained to inform good practice within the network. METHODS: For all children in the EPIC area who had been prescribed epilepsy rescue medication for use in the community a questionnaire was completed by the clinician for each child relating to rescue medication prescribed, the epilepsy syndrome and seizure type. A questionnaire was also completed by the carers about their experience of the use of rescue medication in their child. RESULTS: A total of 203 paediatrician questionnaires were returned and 190 parent/carer questionnaires were returned. Buccal Midazolam was the most popular rescue medication (Buccal Midazolam 110, Rectal Diazepam 85, Paraldehyde 8). Over 80% of the children had a community care plan in place. 90% of carers recalled receiving instruction/training in the administration of rescue medication. The majority (73%) of carers perceived Buccal Midazolam and Rectal Diazepam to be effective in preventing hospital admission. CONCLUSION: Buccal Midazolam in its propriety form is the rescue medication most commonly prescribed by EPIC epilepsy paediatricians. It was felt by families to be the safest (least side effects reported) and the most effective (most likely to terminate seizures) of the rescue medications. Children with severe epilepsy benefit from the use of rescue medications and the number of hospital admissions for prolonged seizures is reduced.
Authors:
V J Klimach;
Publication Detail:
Type:  Journal Article     Date:  2009-01-08
Journal Detail:
Title:  Seizure : the journal of the British Epilepsy Association     Volume:  18     ISSN:  1059-1311     ISO Abbreviation:  Seizure     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-04     Completed Date:  2009-07-23     Revised Date:  2010-05-27    
Medline Journal Info:
Nlm Unique ID:  9306979     Medline TA:  Seizure     Country:  England    
Other Details:
Languages:  eng     Pagination:  343-6     Citation Subset:  IM    
Affiliation:
Colwyn Bay Hosptial, 204 Abergele Road, Colwyn Bay, Conwy, North Wales LL29 8AY, United Kingdom. Val.Klimach@cd-tr.wales.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Buccal
Anticonvulsants / administration & dosage,  adverse effects,  therapeutic use*
Child
Epilepsy / drug therapy*
Female
Humans
Male
Midazolam / administration & dosage,  adverse effects,  therapeutic use*
Questionnaires
Rescue Work / methods,  statistics & numerical data
Residence Characteristics / statistics & numerical data
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anticonvulsants; 59467-70-8/Midazolam
Comments/Corrections
Comment In:
Seizure. 2010 Jun;19(5):310   [PMID:  20447838 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thromboangiitis obliterans with multiple large vessel involvement: case report and analysis of immun...
Next Document:  The constant region of the membrane immunoglobulin mediates B cell-receptor clustering and signaling...